Advertisement
Advertisement
CVS
CVS HEALTH CORPORATION
96.22
USDSponsored
-2.90
-2.93%
Aug 06, 16:00 UTC -4
Closed
After-Market
96.22
0.00
+0.01%
CVS Earnings Reports
Positive Surprise Ratio
CVS beat 40 of 42 last estimates.
95%
Next Report
Date of Next Report
Oct 27, 2026
Estimate for Q3 26 (Revenue/ EPS)
$104.28B
/$1.72
Implied change from Q2 26 (Revenue/ EPS)
-1.71%
/-33.33%
Implied change from Q3 25 (Revenue/ EPS)
+1.37%
/+7.50%
CVS HEALTH CORPORATION earnings per share and revenue
On Aug 05, 2026, CVS reported earnings of 2.58 USD per share (EPS) for Q2 26, beating the estimate of 1.87 USD, resulting in a 37.95% surprise. Revenue reached 106.10 billion, compared to an expected 101.12 billion, with a 4.93% difference. The market reacted with a -5.08% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 20 analysts forecast an EPS of 1.72 USD, with revenue projected to reach 104.28 billion USD, implying an decrease of -33.33% EPS, and decrease of -1.71% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Natera, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.50
Actual
-$0.47
Surprise
+6.67%
Viatris Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.61
Actual
$0.69
Surprise
+12.58%
Sotera Health Company Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.24
Actual
$0.26
Surprise
+7.62%
Concentra Group Holdings Parent, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.42
Actual
$0.52
Surprise
+22.38%
Establishment Labs Holdings Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.34
Actual
-$0.39
Surprise
-13.67%
Progyny, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.34
Actual
$0.55
Surprise
+60.96%
Nutex Health Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$5.05
Actual
$9.58
Surprise
+89.59%
Omada Health, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.01
Actual
$0.15
Surprise
+1,020.25%
CryoPort, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.19
Actual
-$0.20
Surprise
-1.16%
Shoulder Innovations, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.46
Surprise
+2.85%
FAQ
What were CVS HEALTH CORPORATION's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, CVS HEALTH CORPORATION reported EPS of $2.58, beating estimates by 37.95%, and revenue of $106.10B, 4.93% above expectations.
How did the market react to CVS HEALTH CORPORATION's Q2 2026 earnings?
The stock price moved down -5.08%, changed from $104.42 before the earnings release to $99.12 the day after.
When is CVS HEALTH CORPORATION expected to report next?
The next earning report is scheduled for Oct 27, 2026.
What are the forecasts for CVS HEALTH CORPORATION's next earnings report?
Based on 20
analysts, CVS HEALTH CORPORATION is expected to report EPS of $1.72 and revenue of $104.28B for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement